Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
LEUNG SANDRAGeneral Counsel & Secretary
|
Exercise / conversionCommon Stock, $0.10 par value | 49,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007110 · doc4.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Bancroft Charles AEVP & Chief Financial Officer
|
OtherPerformance Shares · Derivative | 1,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007111 · doc4.xml · derivative · entry 9 Bancroft Charles A · CIK 0001480250 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,216 Underlying: Common Stock, $0.10 par value · 1,213 shares Expires 2014-03-31 F15 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F16 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. F15 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F15 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Bancroft Charles AEVP & Chief Financial Officer
|
GrantPerformance Shares · Derivative | 27,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007111 · doc4.xml · derivative · entry 8 Bancroft Charles A · CIK 0001480250 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,003 Underlying: Common Stock, $0.10 par value · 27,003 shares Expires 2014-03-31 F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F14 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F13 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Bancroft Charles AEVP & Chief Financial Officer
|
Exercise / conversionPerformance Shares · Derivative | 11,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007111 · doc4.xml · derivative · entry 7 Bancroft Charles A · CIK 0001480250 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,413.7047 Underlying: Common Stock, $0.10 par value · 11,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F12 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Bancroft Charles AEVP & Chief Financial Officer
|
OtherPerformance Shares · Derivative | 1,350.5447 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007111 · doc4.xml · derivative · entry 6 Bancroft Charles A · CIK 0001480250 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,738.7047 Underlying: Common Stock, $0.10 par value · 1,350.5447 shares Expires not disclosed F10 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F11 · shares: Represents dividend equivalents earned under the 2010-2012 Long-Term Performance Award. F10 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F10 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F7 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Bancroft Charles AEVP & Chief Financial Officer
|
GrantPerformance Shares · Derivative | 4,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007111 · doc4.xml · derivative · entry 5 Bancroft Charles A · CIK 0001480250 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,388.16 Underlying: Common Stock, $0.10 par value · 4,039 shares Expires not disclosed F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · shares: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F7 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Bancroft Charles AEVP & Chief Financial Officer
|
GrantPerformance Shares · Derivative | 15,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007111 · doc4.xml · derivative · entry 4 Bancroft Charles A · CIK 0001480250 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,349.16 Underlying: Common Stock, $0.10 par value · 15,846 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F6 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F5 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F7 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Bancroft Charles AEVP & Chief Financial Officer
|
GrantMarket Share Units · Derivative | 29,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007111 · doc4.xml · derivative · entry 3 Bancroft Charles A · CIK 0001480250 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,293 Underlying: Common Stock, $0.10 par value · 29,293 shares Expires 2016-03-06 F3 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Bancroft Charles AEVP & Chief Financial Officer
|
Tax withholdingCommon Stock, $0.10 par value | 4,626 | $32.33 | $149,558.58 |
DisclosureSEC source: 0001225208-12-007111 · doc4.xml · nonDerivative · entry 2 Bancroft Charles A · CIK 0001480250 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,795.25 F2 · shares: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Bancroft Charles AEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 11,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007111 · doc4.xml · nonDerivative · entry 1 Bancroft Charles A · CIK 0001480250 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,421.25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caldarella Joseph CSVP & Controller
|
OtherPerformance Shares · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007112 · doc4.xml · derivative · entry 10 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,163 Underlying: Common Stock, $0.10 par value · 308 shares Expires 2014-03-31 F16 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F17 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. F16 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F16 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caldarella Joseph CSVP & Controller
|
GrantPerformance Shares · Derivative | 6,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007112 · doc4.xml · derivative · entry 9 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,855 Underlying: Common Stock, $0.10 par value · 6,855 shares Expires 2014-03-31 F14 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F15 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. F14 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F14 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caldarella Joseph CSVP & Controller
|
Exercise / conversionPerformance Shares · Derivative | 11,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007112 · doc4.xml · derivative · entry 8 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,819.0864 Underlying: Common Stock, $0.10 par value · 11,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F9 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F13 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caldarella Joseph CSVP & Controller
|
OtherPerformance Shares · Derivative | 422.0364 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007112 · doc4.xml · derivative · entry 7 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,144.0864 Underlying: Common Stock, $0.10 par value · 422.0364 shares Expires not disclosed F11 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F12 · shares: Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award. F11 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F11 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F8 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caldarella Joseph CSVP & Controller
|
GrantPerformance Shares · Derivative | 4,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007112 · doc4.xml · derivative · entry 6 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,722.05 Underlying: Common Stock, $0.10 par value · 4,039 shares Expires not disclosed F9 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F10 · shares: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F9 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caldarella Joseph CSVP & Controller
|
GrantPerformance Shares · Derivative | 4,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007112 · doc4.xml · derivative · entry 5 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,683.05 Underlying: Common Stock, $0.10 par value · 4,953 shares Expires not disclosed F6 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F7 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award. F6 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F6 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F8 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caldarella Joseph CSVP & Controller
|
GrantMarket Share Units · Derivative | 7,723 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007112 · doc4.xml · derivative · entry 4 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,723 Underlying: Common Stock, $0.10 par value · 7,723 shares Expires 2016-03-06 F4 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F5 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. F5 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caldarella Joseph CSVP & Controller
|
Tax withholdingCommon Stock, $0.10 par value | 4,585 | $32.33 | $148,233.05 |
DisclosureSEC source: 0001225208-12-007112 · doc4.xml · nonDerivative · entry 2 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,314 F2 · shares: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caldarella Joseph CSVP & Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 11,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007112 · doc4.xml · nonDerivative · entry 1 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
OtherPerformance Shares · Derivative | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007113 · doc4.xml · derivative · entry 9 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,324 Underlying: Common Stock, $0.10 par value · 186 shares Expires 2014-03-31 F13 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F14 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. F13 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F13 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
GrantPerformance Shares · Derivative | 4,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007113 · doc4.xml · derivative · entry 8 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,138 Underlying: Common Stock, $0.10 par value · 4,138 shares Expires 2014-03-31 F11 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F12 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. F11 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F11 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
OtherPerformance Shares · Derivative | 215.1952 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007113 · doc4.xml · derivative · entry 7 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,645.1952 Underlying: Common Stock, $0.10 par value · 215.1952 shares Expires 2013-03-31 F9 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F10 · shares: Represents dividend equivalents earned under the 2010-2012 Long-Term Performance Award. F9 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F9 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
GrantPerformance Shares · Derivative | 3,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007113 · doc4.xml · derivative · entry 6 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,430 Underlying: Common Stock, $0.10 par value · 3,353 shares Expires 2013-03-31 F7 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F8 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award. F7 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F7 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
Exercise / conversionPerformance Shares · Derivative | 8,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007113 · doc4.xml · derivative · entry 5 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 8,811 shares Expires 2012-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F5 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
GrantPerformance Shares · Derivative | 3,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007113 · doc4.xml · derivative · entry 4 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,811 Underlying: Common Stock, $0.10 par value · 3,142 shares Expires 2012-03-31 F5 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F6 · shares: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F5 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
GrantMarket Share Units · Derivative | 11,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007113 · doc4.xml · derivative · entry 3 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,556 Underlying: Common Stock, $0.10 par value · 11,556 shares Expires 2016-03-06 F3 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
Tax withholdingCommon Stock, $0.10 par value | 3,204 | $32.33 | $103,585.32 |
DisclosureSEC source: 0001225208-12-007113 · doc4.xml · nonDerivative · entry 2 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,702.018 F2 · shares: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
Exercise / conversionCommon Stock, $0.10 par value | 8,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007113 · doc4.xml · nonDerivative · entry 1 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,906.018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · derivative · entry 12 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 6,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F19 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F2 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. F2 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
OtherPerformance Shares · Derivative | 4,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · derivative · entry 11 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,065 Underlying: Common Stock, $0.10 par value · 4,172 shares Expires 2014-03-31 F17 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F18 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. F17 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F17 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
GrantPerformance Shares · Derivative | 92,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · derivative · entry 10 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,893 Underlying: Common Stock, $0.10 par value · 92,893 shares Expires 2014-03-31 F15 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F16 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. F15 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F15 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Exercise / conversionPerformance Shares · Derivative | 103,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · derivative · entry 9 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,451.2592 Underlying: Common Stock, $0.10 par value · 103,180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F10 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F14 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
OtherPerformance Shares · Derivative | 7,241.9592 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · derivative · entry 8 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,631.2592 Underlying: Common Stock, $0.10 par value · 7,241.9592 shares Expires not disclosed F12 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F13 · shares: Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award. F12 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F12 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F9 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
GrantPerformance Shares · Derivative | 36,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · derivative · entry 7 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,389.3 Underlying: Common Stock, $0.10 par value · 36,790 shares Expires not disclosed F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F11 · shares: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F10 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
GrantPerformance Shares · Derivative | 84,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · derivative · entry 6 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,599.3 Underlying: Common Stock, $0.10 par value · 84,971 shares Expires not disclosed F7 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F8 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award. F7 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F7 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F9 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
GrantMarket Share Units · Derivative | 116,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · derivative · entry 5 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,959 Underlying: Common Stock, $0.10 par value · 116,959 shares Expires 2016-03-06 F5 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F6 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. F6 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Tax withholdingCommon Stock, $0.10 par value | 52,076 | $32.33 | $1,683,617.08 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · nonDerivative · entry 4 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,105 F4 · shares: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Tax withholdingCommon Stock, $0.10 par value | 3,332 | $32.33 | $107,723.56 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · nonDerivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,181 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 103,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007114 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionRestricted Stock Units · Derivative | 6,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 13 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F20 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F2 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. F2 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
OtherPerformance Shares · Derivative | 1,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 12 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,911 Underlying: Common Stock, $0.10 par value · 1,457 shares Expires 2014-03-31 F18 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F19 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. F18 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F18 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
GrantPerformance Shares · Derivative | 32,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 11 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,454 Underlying: Common Stock, $0.10 par value · 32,454 shares Expires 2014-03-31 F16 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F17 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. F16 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F16 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionPerformance Shares · Derivative | 78,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 10 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,972.9577 Underlying: Common Stock, $0.10 par value · 78,955 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F11 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F11 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F15 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
OtherPerformance Shares · Derivative | 2,879.4177 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,927.9577 Underlying: Common Stock, $0.10 par value · 2,879.4177 shares Expires not disclosed F13 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F14 · shares: Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award. F13 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F13 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F10 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
GrantPerformance Shares · Derivative | 28,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 8 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,048.54 Underlying: Common Stock, $0.10 par value · 28,152 shares Expires not disclosed F11 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F12 · shares: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F11 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F11 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F10 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
GrantPerformance Shares · Derivative | 33,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 7 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,896.54 Underlying: Common Stock, $0.10 par value · 33,783 shares Expires not disclosed F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F9 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award. F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F8 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F10 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
GrantMarket Share Units · Derivative | 35,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 6 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,207 Underlying: Common Stock, $0.10 par value · 35,207 shares Expires 2016-03-06 F6 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F7 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. F7 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Tax withholdingCommon Stock, $0.10 par value | 36,597 | $32.33 | $1,183,181.01 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,840 F4 · shares: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 02:27 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Tax withholdingCommon Stock, $0.10 par value | 3,187 | $32.33 | $103,035.71 |
DisclosureSEC source: 0001225208-12-007115 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,437 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.